OMass Therapeutics
PrivateLast Round
Series B
Extension
May 15, 2023
Est. Valuation
$498M
Total Funding Raised
$166.1M
Company Overview
OMass Therapeutics is a biotechnology company that discovers and develops novel small molecule medicines for rare diseases and immunological conditions using its proprietary structural mass spectrometry technology platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OMass Therapeutics Comparables
Compare OMass Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Confo Therapeutics | 79% | |
| HotSpot Therapeutics | 78% | |
| Frontier Medicines | 78% | |
OMass Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 15, 2023 | ||||
| Series B | Apr 28, 2022 | ||||
| Series A Extension | Feb 17, 2020 | ||||
| Series A | Nov 20, 2018 |
OMass Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series B Extension, Series B |
| Syncona | Series B, Series B Extension, Series A Extension, Series A |
| Oxford Science Enterprises | Series A Extension, Series B, Series B Extension, Series A |
| British Patient Capital | Series B Extension |
| Northpond Ventures | Series B Extension, Series B |
| University of Oxford | Series A Extension, Series B |
| Sanofi Ventures | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
Company faces lawsuit over intellectual property dispute.
- Jan 28, 2026
Jonathan Montagu appointed as new Board Chair.
OMass Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OMass Therapeutics's valuation, stock price, and market status.